NYSE:SENS Senseonics (SENS) Stock Price, News & Analysis $0.46 +0.01 (+1.74%) Closing price 04:00 PM EasternExtended Trading$0.46 +0.00 (+0.15%) As of 07:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Senseonics Stock (NYSE:SENS) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Senseonics alerts:Sign Up Key Stats Today's Range$0.45▼$0.4650-Day Range$0.43▼$0.5852-Week Range$0.25▼$1.40Volume6.49 million shsAverage Volume7.91 million shsMarket Capitalization$370.92 millionP/E RatioN/ADividend YieldN/APrice Target$1.54Consensus RatingBuy Company Overview Senseonics Holdings, Inc. is a medical technology company focused on the development and commercialization of innovative continuous glucose monitoring (CGM) systems for people with diabetes. Since its founding in 2011 and headquartered in Germantown, Maryland, the company has pioneered an implantable sensor designed to deliver long-term glucose readings. Senseonics’ mission centers on improving diabetes management by providing accurate, real-time data to patients and healthcare providers. The company’s flagship offering is the Eversense CGM System, which features a small, fully implantable sensor placed beneath the skin to measure glucose levels for up to 90 days in the United States and up to 180 days in Europe. The system pairs with a wearable transmitter and a mobile application, allowing users to track glucose trends, set alerts, and share data with clinicians. Senseonics supports ongoing research and development to expand its product portfolio and enhance sensor longevity and accuracy. Senseonics holds regulatory approvals including FDA clearance in the United States and CE marking in the European Union, enabling commercialization across key global markets. The company has established partnerships with diabetes care providers and distributors throughout North America and Europe, with additional plans to extend its presence in regions such as the Middle East and Asia-Pacific. Under the leadership of President and Chief Executive Officer Timothy Goodnow, Senseonics continues to build its commercial footprint and pursue strategic collaborations to advance patient access to its long-term CGM technology.AI Generated. May Contain Errors. Read More Senseonics Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks40th Percentile Overall ScoreSENS MarketRank™: Senseonics scored higher than 40% of companies evaluated by MarketBeat, and ranked 769th out of 954 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.5 / 5Analyst RatingBuy Consensus RatingSenseonics has received a consensus rating of Buy. The company's average rating score is 3.40, and is based on 3 buy ratings, no hold ratings, and no sell ratings.Upside PotentialSenseonics has a consensus price target of $1.54, representing about 237.7% upside from its current price of $0.46.Amount of Analyst CoverageSenseonics has only been the subject of 4 research reports in the past 90 days.Read more about Senseonics' stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Senseonics are expected to grow in the coming year, from ($0.14) to ($0.12) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Senseonics is -3.50, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Senseonics is -3.50, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioSenseonics has a P/B Ratio of 6.50. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted8.50% of the float of Senseonics has been sold short.Short Interest Ratio / Days to CoverSenseonics has a short interest ratio ("days to cover") of 7.8.Change versus previous monthShort interest in Senseonics has recently increased by 0.49%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldSenseonics does not currently pay a dividend.Dividend GrowthSenseonics does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted8.50% of the float of Senseonics has been sold short.Short Interest Ratio / Days to CoverSenseonics has a short interest ratio ("days to cover") of 7.8.Change versus previous monthShort interest in Senseonics has recently increased by 0.49%, indicating that investor sentiment is decreasing. News and Social Media1.1 / 5News SentimentN/A Search Interest28 people have searched for SENS on MarketBeat in the last 30 days. This is an increase of 87% compared to the previous 30 days.MarketBeat Follows15 people have added Senseonics to their MarketBeat watchlist in the last 30 days. This is an increase of 67% compared to the previous 30 days. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Senseonics insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 3.60% of the stock of Senseonics is held by insiders.Percentage Held by InstitutionsOnly 12.36% of the stock of Senseonics is held by institutions.Read more about Senseonics' insider trading history. Receive SENS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Senseonics and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SENS Stock News HeadlinesSenseonics Holdings, Inc. (SENS) Eversense 365 Commercial Update Call (Transcript)September 4, 2025 | seekingalpha.comSenseonics signs MOU with Ascensia Diabetes CareSeptember 3, 2025 | msn.comTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.September 18 at 2:00 AM | Porter & Company (Ad)Ascensia Diabetes Care Signs MOU to Transfer Eversense® CGM Distribution to Strategic Partner SenseonicsSeptember 3, 2025 | businesswire.comSenseonics Signs Memorandum of Understanding with Ascensia Diabetes Care to Take Over Commercialization and Distribution of Eversense 365September 3, 2025 | globenewswire.comSenseonics Holdings, Inc. (SENS) Q2 2025 Earnings Call TranscriptAugust 6, 2025 | seekingalpha.comSenseonics Holdings, Inc. Reports Second Quarter Financial ResultsAugust 6, 2025 | globenewswire.comSenseonics Holdings, Inc. Schedules Second Quarter 2025 Earnings Release and Conference Call ...July 16, 2025 | gurufocus.comSee More Headlines SENS Stock Analysis - Frequently Asked Questions How have SENS shares performed this year? Senseonics' stock was trading at $0.5234 on January 1st, 2025. Since then, SENS shares have decreased by 13.0% and is now trading at $0.4553. How were Senseonics' earnings last quarter? Senseonics Holdings, Inc. (NYSE:SENS) released its quarterly earnings results on Monday, March, 3rd. The company reported ($0.12) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.03) by $0.09. Senseonics had a negative net margin of 362.30% and a negative trailing twelve-month return on equity of 842.25%. When did Senseonics IPO? Senseonics (SENS) raised $45 million in an initial public offering (IPO) on Friday, March 18th 2016. The company issued 15,800,000 shares at $2.85 per share. Leerink Partners, Canaccord Genuity and Raymond James acted as the underwriters for the IPO and BTIG was co-manager. Who are Senseonics' major shareholders? Senseonics' top institutional shareholders include First Light Asset Management LLC (5.46%), Geode Capital Management LLC (1.33%), Hood River Capital Management LLC (1.21%) and Sio Capital Management LLC (0.74%). Insiders that own company stock include Timothy T Goodnow, Frederick T Sullivan, Douglas A Roeder and Sharon Larkin. View institutional ownership trends. How do I buy shares of Senseonics? Shares of SENS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Senseonics own? Based on aggregate information from My MarketBeat watchlists, some other companies that Senseonics investors own include Zomedica (ZOM), American Water Works (AWK), Waste Connections (WCN), AU Optronics (AUOTY), DiamondRock Hospitality (DRH), The RMR Group (RMR) and Voyager Therapeutics (VYGR). Company Calendar Last Earnings3/03/2025Today9/18/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Process control instruments Sub-IndustryMeasuring And Control Equipment Current SymbolNYSE:SENS Previous SymbolNYSE:SENS CIK1616543 Webwww.senseonics.com Phone301-515-7260Fax301-515-0988Employees90Year FoundedN/APrice Target and Rating Average Price Target for Senseonics$1.54 High Price Target$2.00 Low Price Target$1.25 Potential Upside/Downside+237.7%Consensus RatingBuy Rating Score (0-4)3.40 Research Coverage5 Analysts Profitability EPS (Trailing Twelve Months)($0.10) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$60.39 million Net Margins-362.30% Pretax Margin-362.26% Return on Equity-842.25% Return on Assets-67.99% Debt Debt-to-Equity Ratio59.17 Current Ratio2.47 Quick Ratio2.38 Sales & Book Value Annual Sales$25.47 million Price / Sales14.57 Cash FlowN/A Price / Cash FlowN/A Book Value$0.07 per share Price / Book6.50Miscellaneous Outstanding Shares814,681,000Free Float573,895,000Market Cap$370.92 million OptionableN/A Beta0.93 Social Links 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free Report This page (NYSE:SENS) was last updated on 9/18/2025 by MarketBeat.com Staff From Our PartnersREVEALED: Something Big Happening Behind White House Doorswhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredWarren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the NasdaqNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredCritical AI announcement set to ignite AI 2.0I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredNVIDIA's Worst Nightmare?$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the ...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Senseonics Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Senseonics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.